Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients

NCT04151459 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-11-05

No results posted yet for this study

Summary

This is a experimental study, which subjects are obese PCOS patients requiring LSG surgery. Aim to investigate the effects of LSG surgery in PCOS patients whether increases the live birth rate of the offspring.

Conditions

  • Polycystic Ovary Syndrome
  • Severe Obesity
  • Laparoscopic Sleeve Gastrectomy

Interventions

DRUG

Metformin

Use Metformin for 3 months to treat PCOS

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Tao Tao, MD · RenJi Hospital Department of Endocrinology and Metabolism

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2022-01-15
Completion
2022-01-15

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04151459 on ClinicalTrials.gov